Market Tracker

10/24 6:05pm ET

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

9.37
Data as of Oct 24
 +0.245 / +2.69%
Today’s Change
2.05
Today|||52-Week Range
9.45
+75.67%
Year-to-Date

Today’s Trading

Previous close9.12
Today’s open9.14
Day’s range8.95 - 9.45
Volume2,728,826
Average volume (3 months)2,007,852
Market cap$979.5M
Dividend yield--
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)-5.32%
Earnings growth (this year)+33.33%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)-2.32%
P/E ratioNM
Price/Sales11.04
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SAGESAGE Therapeutics In...+2.94+8.27%
SRPTSarepta Therapeutics...+0.52+2.26%
EPZMEpizyme Inc-0.18-0.60%
TSROTESARO Inc+0.82+3.01%
Data as of 3:59pm ET, 10/24/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$47.8M
Annual profit (last year)-$130.9M
Net profit margin-273.98%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Senior Vice President-
Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts